Comparison of Observed and Expected Numbers of Detected Cancers in the Research Center for Cancer Prevention and Screening Program
Open Access
- 11 May 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 36 (5) , 301-308
Abstract
Background: The Research Center for Cancer Prevention and Screening program is a one-arm prospective study designed to evaluate the effect of multiple modalities for cancer screening. Basic programs consist of screening tests for cancer of the lung, esophagus, stomach, colon, rectum, liver, gall bladder, pancreas and kidneys, in addition to prostate cancer screening for males and breast, cervical, endometrial and ovarian cancer screenings for females. Objective: To investigate the possibility of overdiagnosis, we compared the observed numbers with expected numbers based on the model. Methods: We calculated the expected number of cancers on the basis of negative or positive history of screening tests within the previous year, based on assumed sensitivity and sojourn time. Observed numbers of screen-detected cases for stomach, colorectal, lung, prostate and breast cancer were compared with expected numbers. Results: From February 2004 to January 2005, 3786 participants were enrolled in our study. The overall cancer detection rate was 5.8% (119/2061) for males and 4.1% (71/1725) for females. No statistically significant difference was found between observed and expected cases for colorectal cancer screening, gastric cancer screening for females and lung cancer screening for males. Observed numbers of breast, prostate and lung cancer for females exceeded those expected (P < 0.05). Conclusions: Although cancer screening programs in the present study increased the detection of potentially curable cancers, these modalities, particularly lung, breast and prostate screening, might detect cancers which would not necessarily be clinically significant. We should therefore weigh up benefit and harm for such cancer screening programs.Keywords
This publication has 24 references indexed in Scilit:
- 20-Year Outcomes Following Conservative Management of Clinically Localized Prostate CancerJAMA, 2005
- Lead time associated with screening for prostate cancerInternational Journal of Cancer, 2003
- Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor featuresUrology, 2002
- Prostate-specific antigen-based early detection of prostate cancer—validation of screening without rectal examinationUrology, 2001
- Colorectal cancer mass-screening: Estimation of faecal occult blood test sensitivity, taking into account cancer mean sojourn timeInternational Journal of Cancer, 1997
- Efficacy of breast cancer screening by age. New results swedish two-county trialCancer, 1995
- A Prospective Evaluation of Plasma Prostate-Specific Antigen for Detection of Prostatic CancerJAMA, 1995
- Serum concentrations of prostate specific antigen and its complex with α1-antichymotrypsin before diagnosis of prostate cancerThe Lancet, 1994
- Natural History of Changes in Prostate Specific Antigen in Early Stage Prostate CancerJournal of Urology, 1994
- The natural history of lung cancer estimated from the results of a randomized trial of screeningCancer Causes & Control, 1992